Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention
Recruiting now · Not applicable
Conditions studied: HIV Seropositivity
In brief
The goal of this Hybrid Type I effectiveness-implementation trial is to test an evidence-based, flexible, and tailored intervention that leverages existing social network members to promote retention in care and viral suppression among people living with HIV aged 18-49.
Key facts
- Study ID
- NCT05723653
- Run by
- University of Chicago
- People needed
- 900
- Starts
- 2023-02-13
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-04-08
Who can join
Age: 18 and older, up to 49. Sex: any. Healthy volunteers: accepted.
You may not qualify if…
- Romantic/Sexual partners of Index participant
- Relationship strain or abuse present in Index-Support Confidant relationship
Where it is running
- Howard Brown Health — Chicago, Illinois, United States (enrolling)
- Birmingham AIDS Outreach — Birmingham, Alabama, United States (enrolling)
- Thrive Alabama — Huntsville, Alabama, United States (enrolling)
- Chicago Center for HIV Elimination — Chicago, Illinois, United States (enrolling)
- Tulane University — New Orleans, Louisiana, United States
- Crown Family School of Social Work, Policy, and Practice at the University of Chicago — Chicago, Illinois, United States
- University of Alabama at Birmingham 1917 Clinic — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.